Therapeutic targeting of polycomb and BET bromodomain proteins in diffuse intrinsic pontine gliomas

Piunti, Andrea, Hashizume, Rintaro, Morgan, Marc A, Bartom, Elizabeth T, Horbinski, Craig M, Marshall, Stacy A, Rendleman, Emily J, Ma, Quanhong +9 more·2017·Nature Medicine
DOI 10.1038/nm.4296

Cited by (458)

Items 201–300 of 458

  1. Redistribution of EZH2 promotes malignant phenotypes by rewiring developmental programmes
    Thomas Mortimer, Elanor N. Wainwright, Harshil Patel, Bernard M. Siow, Zane Jaunmuktane, Sebastian Brandner, Paola Scaffidi · 2019 · EMBO Reports
  2. A Chemical Strategy toward Novel Brain-Penetrant EZH2 Inhibitors
    Rui Liang, Daisuke Tomita, Yusuke Sasaki, John D. Ginn, Mayako Michino, David J. Huggins, Leigh A. Baxt, Stacia Kargman, Maaz Shahid, Kazuyoshi Aso et al. · 2022 · ACS Medicinal Chemistry Letters
  3. Mechanisms of Histone Modifications
    Ludovica Vanzan, Athéna Sklias, Maria Bošković, Zdenko Herceg, Rabih Murr, David M. Suter · 2022 · Elsevier eBooks
  4. Advances on Epigenetic Drugs for Pediatric Brain Tumors
    Panagiotis Skouras, Mariam Markouli, Dimitrios Strepkos, Christina Piperi · 2022 · Current Neuropharmacology
  5. Defining super-enhancers by highly ranked histone H4 multi-acetylation levels identifies transcription factors associated with glioblastoma stem-like properties
    Nando Dulal Das, Jen-Chien Chang, Chung-Chau Hon, S. Thomas Kelly, Shinsuke Ito, Marina Lizio, Bogumił Kaczkowski, Hisami Watanabe, Keisuke Katsushima, Atsushi Natsume et al. · 2023 · BMC Genomics
  6. Histone H3K27M Mutation in Brain Tumors
    Ahmed H. K. El-Hashash · 2020 · Advances in experimental medicine and biology
  7. Advanced Pediatric Diffuse Pontine Glioma Murine Models Pave the Way towards Precision Medicine
    Zirong Chen, Peng Peng, Xiaolin Zhang, Barbara L. Mania-Farnell, Guifa Xi, Feng Wan · 2021 · Cancers
  8. Janus Bioparticles: Asymmetric Nucleosomes and Their Preparation Using Chemical Biology Approaches
    Michelle M. Mitchener, Tom W. Muir · 2021 · Accounts of Chemical Research
  9. Diffuse intrinsic pontine gliomas: Diagnostic approach and treatment strategies
    M. Burhan Janjua, Vin Shen Ban, Tarek Youssef El Ahmadieh, Steven Wei-Hung Hwang, Amer F. Samdani, Angela V. Price, Bradley E. Weprin, H. Hunt Batjer · 2019 · Journal of Clinical Neuroscience
  10. Multiple modes of PRC2 inhibition elicit global chromatin alterations in H3K27M pediatric glioma
    James M. Stafford, Chul‐Hwan Lee, Philipp Voigt et al. · 2018 · bioRxiv (Cold Spring Harbor Laboratory)
  11. Latest Advancements in the Management of H3K27M-Mutant Diffuse Intrinsic Pontine Glioma: A Narrative Review
    Maria Chiara Lo Greco, Giorgia Marano, Madalina La Rocca et al. · 2025 · Cancers
  12. The Intricate Epigenetic and Transcriptional Alterations in Pediatric High-Grade Gliomas: Targeting the Crosstalk as the Oncogenic Achilles’ Heel
    Paul Huchedé, Pierre Leblond, Marie Castets · 2022 · Biomedicines
  13. Radiotherapy and radio‐sensitization in H3K27M ‐mutated diffuse midline gliomas
    Chao Liu, Shuwen Kuang, Lei Wu, Quan Cheng, Xuan Gong, Jun Wu, Longbo Zhang · 2023 · CNS Neuroscience & Therapeutics
  14. The lysine demethylase KDM4A controls the cell-cycle expression of replicative canonical histone genes
    Capucine Van Rechem, Fei Ji, Sweta Mishra · 2020 · Biochimica et Biophysica Acta (BBA) - Gene Regulatory Mechanisms
  15. REST upregulates gremlin to modulate diffuse intrinsic pontine glioma vasculature
    Shavali Shaik, Bridget A. Kennis, Shinji Maegawa, Keri Schadler, Yang Yanwen, Keri Callegari, Rishi Ramesh Lulla, Stewart Goldman, Javad Nazarian, Veena Rajaram et al. · 2017 · Oncotarget
  16. MutT homolog 1 counteracts the effect of anti-neoplastic treatments in adult and pediatric glioblastoma cells
    Ziv Versano, Eitan Shany, Shany Freedman, Liron Tuval-Kochen, Moshe Leitner, Shoshana Paglin, Amos Toren, Michal Yalon · 2018 · Oncotarget
  17. Immunogenic Cell Death Enhances Immunotherapy of Diffuse Intrinsic Pontine Glioma: From Preclinical to Clinical Studies
    Guohao Liu, Yanmei Qiu, Po Zhang, Zirong Chen, Sui Chen, Weida Huang, Baofeng Wang, Xingjiang Yu, Dongsheng Guo · 2022 · Pharmaceutics
  18. Developing H3K27M mutant selective radiosensitization strategies in diffuse intrinsic pontine glioma
    Leslie A. Parsels, Daniel Richard Wahl, Carl Johannes Koschmann, Meredith Ann Morgan, Qiang Zhang · 2023 · Neoplasia
  19. Systematic Review of Molecular Targeted Therapies for Adult-Type Diffuse Glioma: An Analysis of Clinical and Laboratory Studies
    Logan Muzyka, Nicolas K. Goff, Nikita Ray Choudhary, Michael T. Koltz · 2023 · International Journal of Molecular Sciences
  20. EZHIP’s role in diffuse midline glioma: echoes of oncohistones?
    Afraah Cassim, Matthew D. Dun, David Gallego‐Ortega, Fátima Valdés‐Mora · 2024 · Trends in cancer
  21. G-quadruplex stabilizer CX-5461 effectively combines with radiotherapy to target α-thalassemia/mental retardation X-linked-deficient malignant glioma
    Sharvari Dharmaiah, Prit Benny Malgulwar, William E Johnson, Brandon Chen, Vladislav G. Sharin, Benjamin T. Whitfield, Christian Alvarez, Vasudev Tadimeti, Ahsan Saleem Farooqi, Jason T. Huse · 2024 · Neuro-Oncology
  22. Isolation and characterization of immune cells from the tumor microenvironment of genetically engineered pediatric high-grade glioma models using the sleeping beauty transposon system
    María Belén Garcia-Fabiani, Andrea Comba, Padma Kadiyala, Santiago Haase, Felipe Javier Núñez, David B. Altshuler, Pedro Ricardo Lowenstein, Maria Graciela Castro · 2019 · Methods in enzymology on CD-ROM/Methods in enzymology
  23. H2A.Z histone variants facilitate HDACi-dependent removal of H3.3K27M mutant protein in pediatric high-grade glioma cells
    Katarzyna B. Leszczyńska, Amanda Freitas-Huhtamäki, Chinchu Jayaprakash, Monika Dźwigońska, Francisca N. de Luna Vitorino, Cynthia Horth, Kamil Wojnicki, Bartłomiej Gielniewski, Paulina Szadkowska, Beata Kaza et al. · 2024 · Cell Reports
  24. Diffuse Intrinsic Pontine Gliomas Exhibit Cell Biological and Molecular Signatures of Fetal Hindbrain-Derived Neural Progenitor Cells
    Yu Sun, Cheng Xu, Changcun Pan, Xin Chen, Yibo Geng, Yuliang Wu, Peng Zhang, Wenhao Wu, Yu Wang, Deling Li et al. · 2019 · Neuroscience Bulletin
  25. Chromatin Bottlenecks in Cancer
    Jay F. Sarthy, Steven Henikoff, Kami Ahmad · 2019 · Trends in cancer
  26. The Use of Mononucleosome Immunoprecipitation for Analysis of Combinatorial Histone Post-translational Modifications and Purification of Nucleosome-Interacting Proteins
    Kashif Aziz Khan, Marlee K. Ng, Peter Cheung · 2020 · Frontiers in Cell and Developmental Biology
  27. Enhancer rewiring in tumors: an opportunity for therapeutic intervention
    Laia Richart, François‐Clément Bidard, Raphaël Margueron · 2021 · Oncogene
  28. Epigenetic mechanisms in paediatric brain tumours: regulators lose control
    Sara Badodi, Silvia Marino · 2022 · Biochemical Society Transactions
  29. Fragment‐Based Drug Discovery in the Bromodomain and Extra‐Terminal Domain Family
    Mostafa Radwan, Rabah A.T. Serya · 2017 · Archiv der Pharmazie
  30. NCI-CONNECT: Comprehensive Oncology Network Evaluating Rare CNS Tumors—Histone Mutated Midline Glioma Workshop Proceedings*
    Brett James Theeler, Yamini Dalal, Michelle Monje, Ali Shilatifard, Mario L. Suvà, Orwa Aboud, Kevin A. Camphausen, Christine Cordova, Elizabeth Finch, John D. Heiss et al. · 2020 · Neuro-Oncology Advances
  31. Epigenetic programming of pediatric high-grade glioma: Pushing beyond proof of concept to clinical benefit
    Andrew P. Groves, Tabitha M. Cooney · 2022 · Frontiers in Cell and Developmental Biology
  32. Pathogenic Epigenetic Consequences of Genetic Alterations in IDH-Wild-Type Diffuse Astrocytic Gliomas
    Fumiharu Ohka, Keiko Shinjo, Shoichi Deguchi, Yusuke Matsui, Yusuke Okuno, Keisuke Katsushima, Miho M. Suzuki, Akira Kato, Noboru Ogiso, Akane Yamamichi et al. · 2019 · Cancer Research
  33. Genetic and Epigenetic Alterations in Cancer
    Bin Tean Teh, Eric R. Fearon · 2020 · Elsevier eBooks
  34. A Genetically Encoded Approach for Breaking Chromatin Symmetry
    Bradley J. Lukasak, Robert E. Thompson, Michelle M. Mitchener, Vanessa Feng, John D. Bagert, Tom W. Muir · 2022 · ACS Central Science
  35. Bromodomain and Extra-Terminal Protein Inhibitors: Biologic Insights and Therapeutic Potential in Pediatric Brain Tumors
    Andrew P. Groves, Jessica R. Clymer, Mariella G. Filbin · 2022 · Pharmaceuticals
  36. Leveraging dominant-negative histone H3 K-to-M mutations to study chromatin during differentiation and development
    Ksenia Serdyukova, Alison R. Swearingen, Mariel Coradin, Mika Nevo, Huong Tran, Emir Bajric, Justin Brumbaugh · 2023 · Development
  37. Engineered extracellular vesicles (EVs): Promising diagnostic/therapeutic tools for pediatric high-grade glioma
    Yuan Lyu, Yupei Guo, Chioma M. Okeoma, Zhaoyue Yan, Nan Hu, Zian Li, Shaolong Zhou, Xin Zhao, Junqi Li, Xinjun Wang · 2023 · Biomedicine & Pharmacotherapy
  38. H3 K27M and EZHIP impede H3K27-methylation spreading by inhibiting allosterically stimulated PRC2
    Siddhant U. Jain, Andrew Q. Rashoff, Samuel D. Krabbenhoft et al. · 2020 · bioRxiv (Cold Spring Harbor Laboratory)
  39. Crosstalk of Epigenetic and Metabolic Signaling Underpinning Glioblastoma Pathogenesis
    Mariam Markouli, Dimitrios Strepkos, Kostas A. Papavassiliou, Athanasios G. Papavassiliou, Christina Piperi · 2022 · Cancers
  40. PRC2-independent actions of H3.3K27M in embryonic stem cell differentiation
    Lea R Z Cohen, Binyamin Kaffe, Eden Deri, Chen Leibson, Malka Nissim‐Rafinia, Moria Maman, Nofar Harpaz, Guy Ron, Efrat Shema, Eran Meshorer · 2022 · Nucleic Acids Research
  41. Genome Medicine for Brain Tumors: Current Status and Future Perspectives
    Akitake Mukasa · 2020 · Neurologia medico-chirurgica
  42. Emerging roles of cancer-associated histone mutations in genomic instabilities
    Priyanka Yadav, Ronit Jain, Rajesh Kumar Yadav · 2024 · Frontiers in Cell and Developmental Biology
  43. Single-molecule systems for the detection and monitoring of plasma-circulating nucleosomes and oncoproteins in diffuse midline glioma
    Nir Erez, Noa Furth, Vadim Fedyuk, Jack Wadden, Rayan Aittaleb, Tiffany Adam, Kallen Schwark, Michael Niculcea, Madeline Miclea, Rajen J. Mody et al. · 2025 · Cell Reports Medicine
  44. Catalytic-independent functions of the Integrator–PP2A complex (INTAC) confer sensitivity to BET inhibition
    Pengyu Fan, Xue-Ying Shang, Aixia Song, Shuo Chen, Run-Yuan Mao, Jingchuan Ma, Jiwei Chen, Zhenning Wang, Hai Zheng, Bolin Tao et al. · 2025 · Nature Chemical Biology
  45. Aberrant EZHIP expression drives tumorigenesis in osteosarcoma
    Wajih Jawhar, Geoffroy Danieau, Alva Annett, Takeaki Ishii, Andrea Bajic, Ana Castillo-Orozco, Brian Krug, Yara Faucher-Jabado, Justin Seyedmoomenkashi, Muhammad Saquib et al. · 2025 · Nature Communications
  46. Epigenetic-Targeted Treatments for H3K27M-Mutant Midline Gliomas
    Victor M. Lu, David J. Daniels · 2020 · Advances in experimental medicine and biology
  47. Identification of genes functionally involved in the detrimental effects of mutant histone H3.3-K27M in Drosophila melanogaster
    Johannes Berlandi, Amel Chaouch, Nicolas De Jay, Isabel Tegeder, Katharina Thiel, Margret Shirinian, Claudia L. Kleinman, Astrid Jeibmann, Paul F. Lasko, Nada Jabado et al. · 2019 · Neuro-Oncology
  48. Ganoderic Acid A Enhances Tumor Suppression Function of Oxaliplatin via Inducing the Cytotoxicity of T Cells
    Chengkui Liu, Zhichao Song, Chunhui Wang · 2022 · Anti-Cancer Agents in Medicinal Chemistry
  49. H3K27-altered diffuse midline glioma: a paradigm shifting opportunity in direct delivery of targeted therapeutics
    Julian S. Rechberger, Blake T. Power, Erica A. Power, Cody L. Nesvick, David J. Daniels · 2023 · Expert Opinion on Therapeutic Targets
  50. LIN28B and Let-7 in Diffuse Midline Glioma: A Review
    Truman Knowles, Tina Huang, Jin Qi, Shejuan An, Noah J. Burket, Scott H. Cooper, Javad Nazarian, Amanda Muhs Saratsis · 2023 · Cancers
  51. Growth inhibitor of human hepatic carcinoma HepG2 cells by evodiamine is associated with downregulation of PRAME
    Hanzhang Zhu, Ke Ge, Jun Lü, Changku Jia · 2019 · Naunyn-Schmiedeberg s Archives of Pharmacology
  52. TOP2B Enzymatic Activity on Promoters and Introns Modulates Multiple Oncogenes in Human Gliomas
    Edgar González-Buendía, Junfei Zhao, Lu Wang, Subhas Mukherjee, Daniel Yang Zhang, Victor Andrés Arrieta, Eric Feldstein, JOSHUA ROBERT KANE, Seong Jae Kang, Catalina Lee-Chang et al. · 2021 · Clinical Cancer Research
  53. Epigenetic Alterations in Bone and Soft Tissue Tumors
    John B. Wojcik, Kumarasen Cooper · 2017 · Advances in Anatomic Pathology
  54. Integration and Intersection of Cancer Metabolism with Epigenetic Pathways in Gliomas
    Siva Kumar Natarajan, Matthew J Pun, James Haggerty-Skeans, Sriram Venneti · 2025 · Annual Review of Pathology Mechanisms of Disease
  55. Preclinical validation of a novel therapeutic strategy for choroid plexus carcinoma
    Brice Martin, Tyler Garman, Madeline Laramee, Amy Wang, Xiaohu Zhang, Erin Beck, Kelli M. Wilson, Carleen A. Klumpp-Thomas, Crystal G. McKnight, Xin Yu Xu et al. · 2023 · Journal of Controlled Release
  56. The role of adjuvant chemotherapy in patients with H3K27 altered diffuse midline gliomas: a multicentric retrospective study
    Vincenzo Di Nunno, Giuseppe Lombardi, Matteo Simonelli et al. · 2024 · Journal of Neuro-Oncology
  57. Targeting the HLA-E–NKG2A axis in combination with MS-275 enhances NK cell-based immunotherapy against DMG
    Yuxuan Deng, Jinqiu Liu, Zhuonan Pu, Yi Wang, Tian Li, Zhuang Jiang, L Z Xie, Xiaoli Zhang, Yi Chen, Mingxu Yang et al. · 2025 · Journal of Experimental & Clinical Cancer Research
  58. A specific form of cPRC1 containing CBX4 is co-opted to mediate oncogenic gene repression in diffuse midline glioma
    Eimear Lagan, Dáire Gannon, Ademar Jesus Silva, Peter Bibawi, Anthony M. Doherty, Darragh Nimmo, Rachel McCole, Craig Monger, Giovani Luiz Genesi, Aurelie Vanderlinden et al. · 2025 · Molecular Cell
  59. Super-enhancer landscape rewiring in cancer: The epigenetic control at distal sites
    Eros Di Giorgio, Roberta Benetti, Emanuela Kerschbamer, Luigi Emilio Xodo, Claudio Brancolini · 2023 · International review of cytology
  60. The many faces of H3.3 in regulating chromatin in embryonic stem cells and beyond
    Lea R Z Cohen, Eran Meshorer · 2024 · Trends in Cell Biology
  61. CDK4/6 and diffuse intrinsic pontine glioma - Evaluate at diagnosis?
    Oren Josh Becher · 2019 · EBioMedicine
  62. Differential kinase activity of ACVR1 G328V and R206H mutations with implications to possible TβRI cross-talk in diffuse intrinsic pontine glioma
    Hongnan Cao, Miao Jin, Mu Gao, Hongyi Zhou, Yizhi Jane Tao, Jeffrey Skolnick · 2020 · Scientific Reports
  63. Promising Chemotherapy for Malignant Pediatric Brain Tumor in Recent Biological Insights
    Qian Zhou, Yichen Xu, Yan Zhou, Jincheng Wang · 2022 · Molecules
  64. Targeting Sphingosine Kinase by ABC294640 against Diffuse Intrinsic Pontine Glioma (DIPG)
    Lu Dai, Jungang Chen, Zhen Nan Lin, Zhaoxiong Wang, Shengyu Mu, Zhiqiang Qin · 2020 · Journal of Cancer
  65. Pediatric Gliomas
    Sophie Peeters, Yagmur Muftuoglu, Brian S Na, David J. Daniels, Anthony Wang · 2021 · Neurosurgery Clinics of North America
  66. Advanced Pediatric Diffuse Pontine Glioma Animal Models Pave the Way Towards Precision Medicine
    Zirong Chen, Peng Peng, Xiaolin Zhang, Barbara L. Mania-Farnell, Guifa Xi, Feng Wan · 2021 · Preprints.org
  67. The Landscape of Pediatric High-Grade Gliomas: The Virtues and Pitfalls of Pre-Clinical Models
    Liam M. Furst, Enola Roussel, Ryan F. Leung, Ankita M. George, Sarah A. Best, James Richard Whittle, Ron Firestein, Maree C. Faux, David D. Eisenstat · 2024 · Biology
  68. An oncohistone-driven H3.3K27M/CREB5/ID1 axis maintains the stemness and malignancy of diffuse intrinsic pontine glioma
    Wei Zhou, Cheng Xu, Shuangrui Yang, Haocheng Li, Changcun Pan, Zhuang Jiang, Luyang Xie, Xiaohan Li, Huimin Qiao, Da Mi et al. · 2025 · Nature Communications
  69. Brain stem gliomas and current landscape
    Brandon M. Wummer, Delaney Woodworth, Catherine Flores · 2021 · Journal of Neuro-Oncology
  70. Pediatric glioblastoma cells are sensitive to drugs that inhibit eIF2α dephosphorylation and its phosphomimetic S51D variant
    Karin Eytan, Ziv Versano, Roni Oren, Jasmine Jacob‐Hirsch, Moshe Leitner, Alon Harmelin, Gideon Rechavi, Amos Toren, Shoshana Paglin, Michal Yalon · 2022 · Frontiers in Oncology
  71. Regulation of Cell Plasticity by Bromodomain and Extraterminal Domain (BET) Proteins: A New Perspective in Glioblastoma Therapy
    Deborah Gargano, Marco Segatto, Sabrina Di Bartolomeo · 2023 · International Journal of Molecular Sciences
  72. PRMT5 inhibition shows in vitro efficacy against H3K27M-altered diffuse midline glioma, but does not extend survival in vivo
    Elizabeth J. Brown, Leire Balaguer‐Lluna, Adam P. Cribbs, Martin Philpott, Leticia Campo, Molly Browne, Jong Fu Wong, Udo C. T. Oppermann, Angel Montero Carcaboso, Alex N. Bullock et al. · 2024 · Scientific Reports
  73. Abnormal expression of menin predicts the pathogenesis and poor prognosis of adult gliomas
    Zhanfeng Wang, Xinyu Hong, Ling-Yu Zhu · 2019 · Cancer Gene Therapy
  74. Decoding the Protein Composition of Whole Nucleosomes with Nuc-MS
    Luis F. Schachner, Kevin Jooß, Marc A. Morgan et al. · 2020 · bioRxiv (Cold Spring Harbor Laboratory)
  75. Drug screening linked to molecular profiling identifies novel dependencies in patient-derived primary cultures of paediatric high grade glioma and DIPG
    Diana M. Carvalho, Sara Temelso, Alan G. Mackay, Helen N. Pemberton, Rebecca F. Rogers, Ketty Kessler, Elisa Izquierdo, Lynn M. Bjerke, Janat Fazal Salom, Matthew Clarke et al. · 2020 · bioRxiv (Cold Spring Harbor Laboratory)
  76. Understanding spinal cord astrocytoma: Molecular mechanism, therapy, and comprehensive management
    Bo Pang, Songyuan An, Yun Liu, Tao Jiang, Wenqing Jia, Ruichao Chai, Yongzhi Wang · 2024 · Cancer Letters
  77. Adaptive immunotherapeutic paradigms in diffuse midline glioma: integrating epigenetic reprogramming, neuron–glioma interactions, and tumor microenvironment modulation
    Justin Liu, Joseph H. Ha, Matthew Alexander Abikenari, Marcus Sjöholm, Shreyas Annagiri, Karthik Ravi, Brandon Hwa-Lin Bergsneider, Rohit Verma, Debebe Theodros, Ravi Teja Medikonda et al. · 2025 · Journal of Neuro-Oncology
  78. The changing chromatome as a driver of disease: A panoramic view from different methodologies
    Isabel Espejo, Luciano Di Croce, Sergi Aranda · 2020 · BioEssays
  79. Chromatin mutations in pediatric high grade gliomas
    Hsiao P. J. Voon, Lee H. Wong · 2023 · Frontiers in Oncology
  80. A novel CDK4/6 inhibitor combined with irradiation demonstrates potent anti-tumor efficacy in diffuse midline glioma
    Pengcheng Zuo, Yaopeng Li, Tantan Wang, Xingyu Lin, Zhen Wu, Junting Zhang, Xuebin Liao, Liwei Zhang · 2023 · Journal of Neuro-Oncology
  81. Nucleosomal asymmetry: a novel mechanism to regulate nucleosome function
    Devisree Valsakumar, Philipp Voigt · 2024 · Biochemical Society Transactions
  82. Targeted detection and quantitation of histone modifications from 1,000 cells
    Nebiyu Ali Abshiru, Jacek W. Sikora, Jeannie M. Camarillo, Juliette A. Morris, Philip Daniel Compton, Tak H. Lee, Yaseswini Neelamraju, Samuel Haddox, Caroline K. Sheridan, Martin P Carroll et al. · 2020 · PLoS ONE
  83. The Application of Peptides in Glioma: A Novel Tool for Therapy
    Li Li, Jianhong Chen, Yue Ming, Bin Li, Ruoqiu Fu, Dongyu Duan, Ziwei Li, Rui Ni, Xianfeng Wang, Yueling Zhou et al. · 2021 · Current Pharmaceutical Biotechnology
  84. Multifaceted regulation of enhancers in cancer
    Qiong Xiao, Yong Xiao, Lianyun Li, Mingkai Chen, Min Wu · 2022 · Biochimica et Biophysica Acta (BBA) - Gene Regulatory Mechanisms
  85. Untangling the role of mutant histone H3 in diffuse intrinsic pontine glioma
    Caretha L. Creasy · 2017 · Nature Medicine
  86. Improving long-term survival in diffuse intrinsic pontine glioma
    James T. Felker, Alberto Broniscer · 2020 · Expert Review of Neurotherapeutics
  87. Dual targeting of histone deacetylases and MYC as potential treatment strategy for H3-K27M pediatric gliomas
    Danielle Algranati, Roni Oren, Bareket Dassa, Liat Fellus-Alyagor, Alexander N. Plotnikov, Haim Michael Barr, Alon Harmelin, Nir London, Guy Ron, Noa Furth et al. · 2024 · eLife
  88. BMP2 and BMP7 cooperate with H3.3K27M to promote quiescence and invasiveness in pediatric diffuse midline gliomas
    Paul Huchedé, Swann Meyer, Clément Berthelot, Maud Hamadou, Adrien Bertrand‐Chapel, Andria Rakotomalala, Line Manceau, Julia Tomine, Nicolas Lespinasse, Paul Lewandowski et al. · 2023 · eLife
  89. Regulation of Genome Architecture in Huntington’s Disease
    Stephanie Portillo‐Ledesma, Minna Hang, Tamar Schlick A · 2025 · Biochemistry
  90. Loss of Polycomb Repressive Complex 2 Function Alters Digestive Organ Homeostasis and Neuronal Differentiation in Zebrafish
    Ludivine Raby, Pamela Völkel, Shaghayegh Hasanpour, Julien Cicero, Robert‐Alain Toillon, Éric Adriaenssens, Isabelle VAN SEUNINGEN, Xuefen Le Bourhis, Pierre‐Olivier Angrand · 2021 · Cells
  91. Brainstem Tumors
    Peter A. Chiarelli, Jason K. Chu, Mark D. Krieger · 2019 · Springer eBooks
  92. Differentiation therapy targeting the stalled epigenetic developmental programs in pediatric high-grade gliomas
    Wang Xiang, Xiaolin Zhang, Minhai Dong, Lijun Wan, Bin Zhang, Feng Wan · 2025 · Pharmacological Research
  93. Dysregulation of chromatin organization in pediatric and adult brain tumors: oncoepigenomic contributions to tumorigenesis and cancer stem cell properties
    Seungil Paik, Francesca Maule, Marco Gallo · 2020 · Genome
  94. Patrimonio cultural y patrimonio natural: ¿Una pareja imposible?
    María Ángeles Querol Fernández · 1995 · Extremadura arqueológica
  95. The Comparative Experimental Study of Sodium and Magnesium Dichloroacetate Effects on Pediatric PBT24 and SF8628 Cell Glioblastoma Tumors Using a Chicken Embryo Chorioallantoic Membrane Model and on Cells In Vitro
    Eligija Damanskienė, Ingrida Balnytė, Angelija Valančiūtė, Vaiva Lesauskaitė, Marta María Alonso, Donatas Stakišaitis · 2022 · International Journal of Molecular Sciences
  96. Fostering open collaboration in drug development for paediatric brain tumours
    Jong Fu Wong, Elizabeth Brown, Eleanor Williams, Alex N. Bullock · 2019 · Biochemical Society Transactions
  97. Spatially controlled construction of assembloids using bioprinting
    Julien George Roth, Lucia Giulia Brunel, Michelle S. Huang, Betty Cai, Yueming Liu, Sauradeep Sinha, Fan Yang, Sergiu P. Pașca, Sungchul Shin, Sarah C. Heilshorn · 2023 · Research Square
  98. Aberrant histone modifications in pediatric brain tumors
    Erin T. Hamanishi, Derek Dang, Sriram Venneti · 2025 · Frontiers in Oncology
  99. The Bermuda Triangle of paediatric brain cancers: epigenetics, developmental timing window and cell of origin
    Afraah Cassim, Yolanda Colino‐Sanguino, Sarah L. Fox, Laura Rodríguez de la Fuente, Hannah E. Hartley, Fátima Valdés‐Mora · 2025 · Cancer and Metastasis Reviews
  100. Combined inhibition of FACT and BET disrupts transcription to suppress tumor growth in mouse models of diffuse midline glioma
    Holly Holliday, Aaminah Khan, Anahid Ehteda, Hieu Nguyen, Samuel E. Ross, Nisitha Jayatilleke, Anjana Gopalakrishnan, Eyden Wang, Yolanda Colino‐Sanguino, Daisy Kavanagh et al. · 2026 · Science Translational Medicine